Cannon Advisors, Inc. Novo Nordisk A S Transaction History
Cannon Advisors, Inc.
- $118 Billion
- Q4 2024
A detailed history of Cannon Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Cannon Advisors, Inc. holds 3,739 shares of NVO stock, worth $329,331. This represents 0.27% of its overall portfolio holdings.
Number of Shares
3,739
Previous 4,410
15.22%
Holding current value
$329,331
Previous $533 Million
39.61%
% of portfolio
0.27%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,881Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.76 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.36 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.14 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.11 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.07 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $199B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...